Corcept Therapeutics Incorporated (CORT) ROE US GAAP (year values)

FY2021 FY2022 FY2023 FY2024 FY2025   LTM ? CAGR 5 years ?
ROE, % ? 29.9% 20.2% 20.9% 20.6% 15.4%   7.51%  
Changes by years, y/y, % +10pp -10pp +1pp 0pp -5pp     -5.4%

Corcept Therapeutics Incorporated. ROE, %

Corcept Therapeutics Incorporated. ROE, changes, pp

Corcept Therapeutics Incorporated (CORT) ROE US GAAP (quarter values)

FY2025Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2026Q1   LTM ?
ROE, % ? 19.5% 20.9% 16.7% 15.4% 7.51%   7.51%
Changes by years, y/y, % -2pp 0pp -5pp -5pp -12pp    
Changes by quarters, q/q, % -1pp +1pp -4pp -1pp -8pp    

Corcept Therapeutics Incorporated. ROE, %

Corcept Therapeutics Incorporated. ROE, changes, pp

Corcept Therapeutics Incorporated. ROE, changes, pp